Kearns-Sayre syndrome

 Contact us
 
Return to database




Prevalence (%) of clinical parameters based on data from 1 references describing 16 individuals







Add new symptom/sign to this disease

Select symptom from list or write it in the box
 Pubmed id number as a reference Organ system affected
Number of patients in the reference Percent affected patients (Between 0 and 1, eg. 0.1 = 10%)
Please provide your name and contact information as a reference
Name Institute Phone number Email address


List of symptoms



Symptom/sign Organ system Percent affected Pubmed id Added on(yyyy-mm-dd) Edit/add reference
Ophthalmoplegia nervous 100 % 17439982 2014-04-29
Retinitis pigmentosa nervous 100 % 17439982 2014-04-29
Ptosis nervous 100 % 17439982 2014-04-29
Cardiac conduction defect circulatory 88 % 17439982 2014-04-29
Muscle weakness skeletal 81 % 17439982 2014-04-29
Hearing loss nervous 56 % 17439982 2014-04-29
Dysphagia nervous 50 % 17439982 2014-04-29
Ataxia nervous 44 % 17439982 2014-04-29
Cardiomyopathy circulatory 25 % 17439982 2014-04-29
Short stature skeletal 25 % 17439982 2014-04-29
Diabetes mellitus endocrine 13 % 17439982 2014-04-29
Tubulopathy urinary 13 % 17439982 2014-04-29



List of references:


Chronic progressive ophthalmoplegia with large-scale mtDNA rearrangement: can we predict progression?
Karine Auré, Hélène Ogier de Baulny, Pascal Laforêt, Claude Jardel, Bruno Eymard, Anne Lombès,



Brain : a journal of neurology - Jun 2007